Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2016Cancer ResearchOpen Access

Combining Epigenetic and Immunotherapy to Combat Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

KCKatherine B. ChiappinelliGeorge Washington UniversityCZCynthia A. ZahnowJohns Hopkins UniversityNANita AhujaUniversity of Wisconsin–Madison

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chiappinelli et al. (2016) studied this question.

synapsesocial.com/papers/6a85656aafd961f1253da090https://doi.org/10.1158/0008-5472.can-15-2125
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses2011 · 67 citations
  2. 2Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-41995 · 2,778 citations
  3. 3Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers2014 · 444 citations